34 unknown. 34 Phase 1, 10 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 34 | Unknown 34 |
| Phase 2 | 10 | Unknown 10 |
Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechanisms of Semaglutide Therapy in Heart Failure Patients Semaglutide - Heart Failure, Obesity | Phase 1 / Phase 2 | Unknown | University Medical Centre Ljubljana | 10 | 2024-07-10 | 2024-08-07 |
| Effect of 4 Weeks of Oral D. Piger on Safety, Pharmacokinetics and Ethanol Metabolism in Overweight Individuals (2023) D piger, Placebo - Obesity, Metabolic Syndrome | Phase 1 | Unknown | Max Nieuwdorp | 20 | 2024-05-01 | 2024-07-16 |
| A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers Xenical® vs EMP 22, EMP 22 vs Xenical®, EMP 16 vs Xenical® - Overweight or Obesity | Phase 1 | Unknown | Empros Pharma AB | 20 | 2023-09-22 | 2023-10-04 |
| A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity HFFS - Osteoarthritis, Knee, Obesity | Phase 1 / Phase 2 | Unknown | University of Southern Mississippi | 24 | 2023-07-01 | 2023-08-18 |
| Evaluation of the Colonization Capacity of a Probiotic Bacterium. Probiotic - Obese, Weight, Body | Phase 1 | Unknown | Valencian Innovation Agency | 15 | 2023-06-01 | 2023-05-26 |
| Comparative Effects of Using Black Seed and Cumin Seed on BCP of Obese Grade I Black Seed ( Nigella Sativa), Cumin Seed (Cuminum Cyminum) - Obese | Phase 1 | Unknown | Sehat Medical Complex | 55 | 2023-01-27 | 2023-03-15 |
| Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients Direct Peritoneal Resuscitation - End Stage Liver DIsease, Obesity | Phase 1 | Unknown | University of Colorado, Denver | 15 | 2022-02-01 | 2023-06-08 |
| Effect of Quinine Hydrochloride in Overweight Population on Food Intake, Hunger and Gut Peptide Release Quinine Hydrochloride, Placebo - Obesity | Phase 1 | Unknown | Universitaire Ziekenhuizen KU Leuven | 40 | 2020-10-29 | 2024-07-03 |
| Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia MET-3 - Obesity, Metabolically Benign | Phase 1 | Unknown | NuBiyota | 20 | 2020-06-22 | 2020-08-11 |
| Bariatric Embolization Trial for the Obese Nonsurgical Left gastric artery embolization - Obesity, Weight Loss | Phase 1 | Unknown | University of Calgary | 5 | 2018-09-01 | 2018-07-26 |
| Evaluation of PK and Biomarkers After UDCA Administrations to Subjects Who Are Overweight and Have Liver Problems Ursodeoxycholic acid, Metformin, Placebo - Overweight, Abnormal Liver Function Tests | Phase 1 | Unknown | Seoul National University Hospital | 30 | 2016-08-01 | 2016-12-23 |
| Obeticholic Acid in Morbidly Obese Patients and Healthy Volunteers Obeticholic acid, Obeticholic acid placebo - Obesity | Phase 1 | Unknown | Sahlgrenska University Hospital | 40 | 2015-08-01 | 2020-08-25 |
| To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subjects KD101, placebo - Obesity | Phase 1 | Unknown | Kwang Dong Pharmaceutical co., ltd. | 38 | 2015-03-01 | 2015-06-03 |
| Effect of Entacapone on Bodyweight Loss in Obese Population Entacapone, Placebo - Obesity | Phase 1 / Phase 2 | Unknown | Kaichun Wu | 30 | 2015-01-01 | 2015-02-02 |
| Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome Deep Brain Stimulation - Prader-Willi Syndrome | Phase 1 | Unknown | University of Sao Paulo General Hospital | 6 | 2014-10-01 | 2015-12-16 |
| New Therapeutic Perspectives in Obesity Phototherapy - Obesity; | Phase 1 | Unknown | Universidade Federal de Sao Carlos | 64 | 2014-09-01 | 2014-06-02 |
| Effects of Intake of a Polysaccharides Mix on Metabolism, Hormones and Satiety in Obese Children. Placebo, Libramed - Obesity | Phase 1 / Phase 2 | Unknown | Azienda Ospedaliera Universitaria Integrata Verona | 120 | 2014-01-01 | 2021-01-13 |
| Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study Enoxaparin 40 mg 2 hours before arm, Enoxaparin 40 mg 12 hours before arm - Morbid Obesity, Pulmonary Embolism | Phase 1 / Phase 2 | Unknown | Mansoura University | 700 | 2013-11-01 | 2015-04-08 |
| Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study Air filled balloon, Bioenteric BIB® balloon - Morbid Obesity, Weight Loss | Phase 1 / Phase 2 | Unknown | Mansoura University | 300 | 2013-09-01 | 2015-04-08 |
| Effect of Gastric Balloon in Morbid Obesity: Prospective Study BMI more than 45 BMI, BMI less than 45 BMI - Morbid Obesity | Phase 1 / Phase 2 | Unknown | Mansoura University | 300 | 2013-08-01 | 2015-04-08 |
Showing 20 of 34. Sign in to see all of them.
Obesity (25) · Obesity, Morbid (5) · Insulin Resistance (4) · Weight Loss (4) · Metabolic Syndrome (3) · Body Weight (2) · Diabetes Mellitus, Type 2 (2) · Heart Failure (2) · Acute Kidney Injury (1) · Atherosclerosis (1) · Bone Resorption (1) · Diabetes, Gestational (1) · End Stage Liver Disease (1) · Fatty Liver (1)
Nutrition Disorders (34) · Nutritional and Metabolic Diseases (34) · Overnutrition (34) · Pathological Conditions, Signs and Symptoms (34) · Signs and Symptoms (33) · Body Weight (31) · Glucose Metabolism Disorders (6) · Hyperinsulinism (6) · Metabolic Diseases (6) · Cardiovascular Diseases (5) · Obesity (5) · Body Weight Changes (4) · Diabetes Mellitus (3) · Endocrine System Diseases (3)
(1-6)-alpha-glucomannan (1) · Adiposity (1) · Cognitive Behavioral Therapy (1) · Deep Brain Stimulation (1) · Diet (1) · Diet, Reducing (1) · Enoxaparin (1) · Exercise (1) · Lasers (1) · Low-Level Light Therapy (1) · Metformin (1) · Nigella sativa oil (1) · Phototherapy (1) · Probiotics (1) · Quinine (1)
Mansoura University (3) · Azienda Ospedaliera Universitaria Integrata Verona (1) · Bayside Health (1) · Central FITT, Inc (1) · Empros Pharma AB (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Federal University of São Paulo (1) · German Diabetes Center (1) · Hospital Sao Joao (1) · Kaichun Wu (1) · Kwang Dong Pharmaceutical co., ltd. (1) · Landspitali University Hospital (1) · Max Nieuwdorp (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · NuBiyota (1)
United States (7) · Belgium (3) · Brazil (3) · Canada (3) · Egypt (3) · Italy (2) · South Korea (2) · Sweden (2) · Australia (1) · China (1) · Germany (1) · Mexico (1) · Netherlands (1) · Pakistan (1) · Portugal (1)
Anahita Mistry, PhD (1) · Andrea Gaggioli, PhD (1) · Claudio Maffeis, MD (1) · Darshan Bakshi, MD (1) · Debra A. Krummel, PhD, RD (1) · Dirk Vissers (1) · Durval Damiani (1) · Emeka Nzekwu, MD (1) · Fiona J Adams, BSc. Grad Dip Diet (1) · Giuseppe Riva, PhD (1) · Gonzalo Torres-Villalobos, MD (1) · Hanns-Ulrich Marschall (1) · Howard Lee, Professor (1) · Hunter B Moore, M.D., P.hD. (1)
PMID 18400730, PMID 18491071, PMID 19142567, PMID 19487105, PMID 20551965, PMID 20847735, PMID 21464376, PMID 21997144, PMID 22136774, PMID 23361157, PMID 24472122, PMID 26084343, PMID 29053802, PMID 36413425, PMID 42028108
2023 (1)